Rovida Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-219,500
| Closed | -$60.6M | – | 37 |
|
2021
Q4 | $60.6M | Hold |
219,500
| – | – | 2.72% | 12 |
|
2021
Q3 | $50.7M | Hold |
219,500
| – | – | 2.15% | 19 |
|
2021
Q2 | $50.4M | Hold |
219,500
| – | – | 2.18% | 16 |
|
2021
Q1 | $41M | Hold |
219,500
| – | – | 1.92% | 18 |
|
2020
Q4 | $37M | Hold |
219,500
| – | – | 2.17% | 16 |
|
2020
Q3 | $32.3M | Hold |
219,500
| – | – | 2.24% | 21 |
|
2020
Q2 | $36M | Buy |
+219,500
| New | +$36M | 3.47% | 9 |
|
2020
Q1 | – | Sell |
-252,600
| Closed | -$33.2M | – | 44 |
|
2019
Q4 | $33.2M | Hold |
252,600
| – | – | 1.76% | 20 |
|
2019
Q3 | $28.2M | Sell |
252,600
-43,700
| -15% | -$4.88M | 1.67% | 20 |
|
2019
Q2 | $32.8M | Hold |
296,300
| – | – | 1.93% | 21 |
|
2019
Q1 | $38.4M | Hold |
296,300
| – | – | 2.61% | 14 |
|
2018
Q4 | $34.3M | Hold |
296,300
| – | – | 2.84% | 14 |
|
2018
Q3 | $31.8M | Hold |
296,300
| – | – | 2.32% | 17 |
|
2018
Q2 | $25.3M | Hold |
296,300
| – | – | 2.08% | 18 |
|
2018
Q1 | $22.9M | Hold |
296,300
| – | – | 2.15% | 18 |
|
2017
Q4 | $25M | Hold |
296,300
| – | – | 2.63% | 16 |
|
2017
Q3 | $25.3M | Hold |
296,300
| – | – | 2.68% | 18 |
|
2017
Q2 | $24.4M | Hold |
296,300
| – | – | 3.36% | 14 |
|
2017
Q1 | $24.9M | Hold |
296,300
| – | – | 4.25% | 11 |
|
2016
Q4 | $21.8M | Buy |
+296,300
| New | +$21.8M | 4.85% | 7 |
|